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ABSTRACT 
 
Common Fragile Sites (CFSs) are regions in which DNA is prone to 
gaps, breaks or constrictions visible on metaphase chromosomes when 
cells are under replicative stressful conditions. 
CFSs are characterized by slow/late replication timing mainly due, 
among other characteristics, to nucleotide sequence which tend to 
form secondary structure, and to the number of active (or inducible) 
replication origins. Recent studies indicate that CFSs expression is 
associated with tissue specificity. In the first part of the work, 
induction and classification of CFSs in two human lung fibroblast cell 
line, IMR-90 and MRC-5, has been done. Cytogenetical identification 
of the most expressed CFSs in both fibroblast cell lines were done: 
1p31.1 and 3q13.3, located on chromosome 1 and 3 respectively, are 
peculiar for this tissue. These regions have typical and confirmed 
CFSs’ characteristics such as expression higher than 3%, high AT 
levels and enrichment in large genes. 
Using genomic databases, searching for causes of their instability were 
done comparing percentage of repetitive elements among the CFSs, 
non-fragile regions (NFRA) and standard genomic sequences. These 
CFSs are characterized by presence of large genes, NEGR1 found in 
1p31.1, LSAMP and ARHGAP31 in the most fragile region of 3q13.3, 
that could be co-responsible for their genomic instability. 
Using probes delimitating fragile regions and combining FISH with IF 
anti-BrdU, analysis of relationship between replication timing and 
fragility was done. Furthermore, comparison between replication 
timing, in normal and stressful condition using APH, was done as well. 
The results obtained for these fragile regions reflect the replication 
timing impairments typical of fragile sites, in both normal and stressful 
conditions. 
The same probes when used in lymphocytes result in a normal 
replication timing, moreover also using CFSs probes specific in 
lymphocytes on fibroblast, results in normal replication timing. 
The results from replication timing analysis are strictly correlated with 
the structural and functional characteristics that are specific of the 
tissues in which these CFSs are expressed. 
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INTRODUCTION 
 
Definition of Fragile Sites. 
Fragile Sites (FSs) are regions in which DNA is prone to gaps, 
breakage or constriction that can be visualized on metaphase 
chromosomes when cells are under replicative stressful condition 
(Durkin and Glover, 2007); they represent about 1% of whole genome 
and their length spans from hundreds to thousands of kilobases. 
The “fragile sites” definition has been used since 1970 when, on long 
arm of chromosome 16, recurrent breaks localized and were also under 
mendelian inheritance (Magenis et al., 1970). 
Investigation on fragile sites was under a particular interest in human 
genetics since some of them, like FS in Xq27.3 region, were recurrent 
in some families but seemed also associated with some pathologies, as 
in mental retardation connected to chromosome X abnormalities 
(Harvey et al, 1977). Thanks to Sutherland, those irregularities on long 
arm of X chromosome were connected to mental retardation in male 
individuals in different Australian families; those chromosomal breaks 
were visible when cells were growth in particular condition. The 
removal of different elements from culture medium such as folic acid 
or thymine seemed to affect in some ways the metabolism of 
nucleotides and DNA replication, resulting in higher X chromosome’s 
abnormalities, connecting mental retardation to this singularity on 
chromosome X (Sutherland, 1979; Glover, 1981). 
The FSs are, moreover, regions in which, following replication, the 
sister chromatids exchange frequency is even higher compared to non-
fragile regions, furthermore they are exogenous viral DNA integration 
sites, so they are recombinogenic and genetically unstable regions 
(Glover et al., 1984; Gaddini et al., 1995). 
Despite these negative features, FSs can still be found in almost every 
organism, from prokaryotes to eukaryotes, suggesting evolutive 
positive selection for these regions and important biological functions 
for cells and their genome. 
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Classification of Fragile Sites. 
The FSs can be categorized in two main classes based on their 
inheritance and population frequency: 
 
- Rare Fragile Sites (RFSs), 
- Common Fragile Sites (CFSs). 
 
 
Figure 1. Common and Rare Fragile Sites classification. Here is shown the 
Fragile Sites classification, the number of associated loci and the characterizing 
sequences (from Durkin and Glover, 2007). 
The Rare Fragile Sites are expressed in less than 5% of all individuals 
in a population (Sutherland, 1984; Schwartz, 2006) and can be further 
categorized based on cells’ culturing condition (figure 1). The folate-
sensitive ones are the most expressed RFSs and are elicited when 
culture medium is folate deprived.  
From a structural point of view, nucleotides repetitions expansions are 
responsible for these regions’ fragility; microsatellites or minisatellites 
with CGGn sequence, because of repetition number and variation in 
population frequency, can cause the occurrence of a fragile allele (Mc 
Murray, 2010) and, in some cases, can also be responsible for 
hereditary pathologies (Sutherland et al., 1984). 
For this class the most known FS is FRAXA associated with X 
chromosome, which co-localize with FMR1 gene responsible for X-
fragile syndrome; the FRAXE RFSs is also associated with mental 
retardation in bearer individuals, it co-localizes with FMR2 gene 
(Verkerk et al., 1991; Gu et al., 1996). 
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The other RFSs are expressed when medium is supplemented with 
distamycin A, an antibiotic, or Bromodeoxyuridine, a thymine 
analogue, but are characterized by AT-rich minisatellites expansion; 
the FRA10B (10q25.2) and FRA16B (16q22.1) are characterized 
respectively by highly repetitive 42 bp and 33 bp minisatellites 
expansion (Hewett et al., 1998; Yu et al., 1997). 
 
The Common Fragile Sites are found in all normal individuals of a 
population, they are part of chromosomes’ normal structure; they are 
categorized by differences in frequency for the same site analyzed and, 
from a molecular point of view, they are not characterized by 
nucleotides expansion (figure 1; Debatisse et al., 2012). 
CFSs characterization started from studies conducted on male 
individual suffering from Martin-Bell syndrome characterized, among 
other features, by mental retardation; peripheral blood lymphocytes 
when cultured in folic acid deprivation conditions expressed a rare 
fragile site on long arm of X chromosome (Xq27.3), named FRAXA 
(Martin and Bell, 1943). Those observations made possible the found 
that another kind of fragile site, named Common Fragile Sites, are 
expressed when cells are cultured in replicative stressful conditions 
induced by molecules acting directly on enzymes responsible for DNA 
replication such as aphidicolin (APH). This molecule at specific 
concentrations inhibits the polymerase complex, acting on α, δ and ε 
subunits causing difficult replicative fork progression in specific DNA 
regions visible as gaps or breaks on metaphase chromosomes upon S 
phase ending (Glover et al., 1984). 
Other molecules can induce CFSs expression acting on replicative 
machinery at different times; the nucleotides analogues 5-azacitidine 
and bromodeoxyuridine must be cited, but the CFSs induced by them 
are less known than those induced by APH. Even Hydroxyurea (HU) 
can induce CFSs but in a less specific way. Finally, environmental 
factors such as smoking, caffeine, oxygen deprivation and diet are 
among factors that increase CFSs expression frequency on human 
chromosomes (Pelliccia and Rocchi, 1992; Dillon et al., 2010). 
As shown in figure 1, the APH induced ones are the human most 
expressed CFSs, however this classification should not be too strict, 
as their expression varies accordingly to APH concentration upon 
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cultured cells and, moreover, some genomic regions are more 
susceptible than others to breaks and lesions.  
The exact number of CFSs it is currently material of debate because is 
dependent by different elements such as concentration and APH action 
duration, in fact, higher is the replicative stress upon cultured cells and  
higher will be CFSs expression frequency at the end of DNA 
replication. It has to be specified that not all CFSs show gaps and/or 
breaks with the same frequency and that only a small number of CFSs 
analyzed so far undergoes chromosomic breaks with a frequency 
higher than 2% (Glover et al., 1984; Yunis and Soreng, 1984); the 
breaks observed in just 20 CFSs embody alone more than 80% of 
lesions observed in all knowing lymphocytes’ CFSs (Glover et al., 
1984). FRA3B (3p14.3) is the most expressed CFS in lymphocytes 
(Ohta et al., 1996; Inoue et al., 1997; Mimori et al., 1999); the other 
highly expressed human lymphocytes CFSs are FRA2G (2q31) 
(Limongi et al., 2003), FRA16D (16q23.2) (Arlt et al., 2002; Ried et 
al., 2000), FRA6E (6q26) (Denison et al., 2003), FRA7H (7q32.3) 
(Mishmar et al., 1998) and FRAXB (Xp22.31) (Glover et al., 1984). 
Their chromosomal localization is shown in figure 2.  
Besides showing differences in gaps or breaks expression, the CFSs 
show other genomic instability associated characteristics. In fact, a 
high Sister Chromatid Exchange (SCE) frequency is observed (Glover 
and Stain,1987; Gaddini et al., 1995) and even a very high rate of 
translocations and deletions in somatic cells hybrid systems (Glover 
and Stain, 1987; Wang et al., 1993); they are preferentially 
recombinational spots and plasmid DNA integration sites in 
transfected cells treated with APH (Rassol et al., 1991), this latter 
characteristic seems to correspond with the observation that in some 
tumors and cancer cell lines the CFSs and the viral integration sites are 
coincident (Wilke et al., 1996). CFSs can also promote chromosomal 
rearrangements and genomic instability, by inducing breaking-fusion-
bridge cycles from breaks, this phenomenon can cause intra-
chromosomal genic amplification as observed in different tumors and 
in vitro in cultured Chinese hamster ovary cells and tumor cell lines 
(Coquelle et al., 1997). 
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Some CFSs can be of significant length and given the number of genes 
within the genome it is not surprising that some of the most expressed 
CFSs co-localize with one or more genes, this is the case of FRA3B 
and FRA16D CFSs that co-localize with FHIT and WWOX genes 
respectively (Ohta et al., 1996; Bednarek et al., 2000). FHIT is a 900 
Figure 2. The Common Fragile Sites. The picture shows Common Fragile Sites 
induced by Aphidicolin and their chromosomes localization; in red are represented 
the most frequent Common Fragile Sites, in blue the less frequent ones (from 
Durkin and Glover, 2007) 
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kb long gene with two large introns that centrally co-localizes with 
FRA3B; this CFS is not characterized by nucleotides repetitions 
expansion but shows the HPV16 virus integration sites responsible for 
cervical cancer (Thorland et al., 2000). FRA16D is co-localizing with 
WWOX gene that spans for over 1 Mb because of two very large 
introns (Ried et al., 2000). 
 
 
The expression of Fragile Sites in different cell types. 
Historically speaking, FSs have been extensively studied in human 
lymphocytes, mostly because of the simplicity in eliciting them in this 
cell type, recently however it has been found that there is a different 
CFSs expression among different cell types. 
The CFSs and their expression can be extremely different among 
different cell types used for their studies (Murano et al., 1989), despite 
the pioneering studies on lymphocytes, different FSs have been 
observed among fibroblasts, epithelial colon cells lines, breast 
erythrocytes cell lines (Hosseini et al., 2013; le Tallec et al., 2013), 
adding more complexity to CFSs classification and expression. 
Using genome-wide approaches such as Repli-seq combined with 
classic cytogenetic techniques, new CFSs have been identified on 
human fibroblast cell lines that differ from the ones localized on 
human lymphocytes (Le Tallec et al., 2011). 
Comparing replication timing of the CFSs in fibroblasts and 
lymphocytes, in the latter the core (the most fragile region in a CFS) 
of FRA3B is replicated from flanking regions’ replicative forks, and 
they must cover long distances before ending replication, suggesting a 
sharp paucity in replicative starting sites; in fibroblasts the same core 
region is replicated in late S phase arriving in G2 with more replicative 
forks localized within core region, pointing out a different number of 
DNA replication starting sites for the same region in different cell 
types (Letessier et al., 2011). Thus, the fragility depends on replicative 
molecular mechanisms, the same in every cell type, while differences 
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has to be found in the chromosomal regions which are different for 
each cell type (figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apart from fibroblasts and lymphocytes, nowadays the CFSs have 
been categorized in colon epithelial cell lines, breast cell lines and 
erythroid cell lines and many of their characterized loci are unstable in 
different tissues but their fragility could vary consistently from one 
cell type to another (Le Tallec et al., 2013). 
 
 
Fragile Sites and Genomic Instability. 
Fragile Sites are expressed when cells are under replicative stressful 
conditions, whether induced by molecules added in culture medium, 
either by external environmental factors like in CFSs, they can also be 
induced by chromosomal regions’ molecular characteristics, like in 
RFSs; so fragile sites expression is connected to replication that must 
be completed without perturbation before cells enter metaphase in 
order to avoid any transmission of mutations. 
Figure 3. The Fragile Sites in lymphocytes and fibroblasts. The figure shows the 
sites that have a breaking frequency higher than 1,5%. The regions with higher 
breaks frequencies of the specific cell types are highlighted with red boxes 
(fibroblasts) and green boxes (lymphocytes) (From Debatisse et al., 2012). 
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In some higher eukaryotes  like mammals, regions of replicative fork 
progression perturbations often appear  and consequently the 
replication rate could vary from one region to another. This is due to 
eukaryotes’ genome complexity both in size and structure, these 
factors can affect replication in different ways, they can be regions 
difficult to replicate because they are naturally subjected to slower fork 
progression rate or they are pausing regions (Cha and Kleckner, 2002; 
Branzei and Foiani, 2010). 
In both RFSs and CFSs the replicative fork progression speed is the 
main cause in their induction, in fact, when the replicative fork 
progression is analyzed, it is often slowed down, so these regions can 
be defined as late replicating regions. 
In RFSs the slower rate in replicative fork progression is due to their 
molecular characteristics, in fact either CGGn trinucleotides 
expansions or repetitive AT-rich regions are present, and it is well 
known how the replication can be difficult when repetitive regions are 
present because the replicative machinery is more  error prone. 
Furthermore, these regions can be difficult to replicate because they 
can lead to the formation of secondary structures known as hairpin 
loops following the intra-chromosomal non-covalent bond of 
complementary sequences that lead to a slower replication fork 
progression in attempt to solve them or, in more severe outcomes, to 
block the replication (Gacy et al., 1995; Hewett et al., 1998). 
Even in CFSs a late replication timing is present. Studies analyzing the 
most expressed CFSs show that some of them can present difficult 
replicative fork progression regions and, because of that, 
chromosomal rearrangements and breaks are much more frequent, 
because they originate from incompletely replicated regions (Hellman 
et al., 2002; Palakodeti et al., 2004). 
This is confirmed by APH mechanism of action upon chromosomal 
replication; it is used to induce CFSs expression. APH addition can 
significantly slow the replication of the most expressed lymphocyte’s 
CFSs, the FRA3B, in which almost 16,5% of the fragile regions 
remain non-replicated upon entering the G2 phase (LeBeau et al., 
1998).  
Experiments on Xenopus’s eggs show that replicative machinery is 
uncoupled from helicase-topoisomerase I molecular complex when 
APH is present in culture medium, this leads to an increased fragile 
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sites expression rate (Pacek et al., 2006; Byun et al., 2005); this 
experiment shows what happens in fragile regions when replication 
fork progression is altered. 
These experiments allowed the formulation of a valid model to explain 
the fragile sites’ expression mechanism that claims that CFSs are 
regions in which the replication is slowed down because the replicative 
machinery is uncoupled from helicase and topoisomerase complexes. 
Treating cells with camptothecin (CPT), a topoisomerase I inhibitor, 
the breaks on CFSs  induced by APH are almost absent (Arlt and 
Glover, 2010).  
Camptothecin is a chemical used as a chemotherapy drug in different 
type of tumors, it acts by reversibly binding the topoisomerase I 
complex preventing DNA re-ligation; high CPT doses are toxic for 
cells because they cause irreversible breaks on DNA. CPT can activate 
the S phase checkpoints’ mechanisms that can stop the DNA synthesis 
even for hours after CPT removal (Horwitz et al., 1971; O’Connor et 
al., 1991). 
In normal cells the helicase-topoisomerase I complex proceeds 
unwinding DNA so the polymerase, which is located behind the 
complex, begins to replicate unwinded regions, leaving few ssDNA 
not yet replicated (figure 4a).  
When cells are treated with low doses of APH the polymerase slows 
the replication rate while the helicase-topoisomerase I complex 
advances in DNA unwinding leaving long regions of exposed non-
replicated ssDNA that activates the checkpoint mechanisms (figure 
4b). 
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These single strand regions could lead to secondary structure 
formation like hairpins or cruciform-like AT-rich secondary structures 
typical of common fragile regions leading to further slowdown of 
replicative complex; in normal conditions the secondary structure 
produced  are identified and resolved, while other escapes from these 
control mechanisms causing the gaps or breaks to be visible on 
metaphase chromosomes, especially on CFSs  regions (Pacek et al., 
2006; Walter et al., 2000). Moreover, in presence of low doses of CPT 
the mechanisms that would resolve the secondary structures are 
slower. 
Finally, when cells are treated with low doses of CPT and APH 
simultaneously, both the polymerasic and helicase-topoisomerase I 
Figure 4. Camptothecin and aphidicolin breaks induction model on CFSs. 
(A) in normal conditions helicases and topoisomerase I complex proceeds 
together. (B) with APH addition the replicative complexes slow the replicative 
rate while the helicase-topoisomerase I proceeds leaving ssDNA non-replicated 
regions exposed. (C) in camptothecin and aphidicolin treated cells both 
complexes slow down (from Arlt and Glover, 2010). 
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complexes slow down, the replication proceeds more slower  and this 
seems to determinate  a lower frequency of ssDNA regions, decreasing 
the secondary structure formation and breaks appearing on metaphase 
chromosomes in CFSs regions (figure 4c). 
This shows how the decoupling of polymerase from helicase complex 
could be the first step in genomic instability associated to CFSs 
regions. 
 
Fragile Sites could also be part of regions with early replication timing. 
Recent studies conducted on mouse B lymphocytes show that the 
cells’ growth in stressful condition induced by hydroxyurea (HU) 
(Barlow et al., 2013) allows a review of replication timing in fragile 
regions. HU acts on S phase, inhibiting the ribonucleotide reductase, 
lowing the synthesis of deoxyribonucleotides from ribonucleotides 
(Szekeres et al., 1997). The damage induced by this drug can be found 
in an early phase of the cell cycle, causing DNA damage in a different 
way than APH, triggering the definition of a new class of fragile sites 
named Early Replicating Fragile Sites (ERFSs). 
The characteristics associated with this new class of fragile sites are 
opposite to CFSs, starting from their expression timing during cell 
cycle: ERFSs in fact are expressed during the earliest phases of cell 
cycle, while it is known that late replication timing is associated with 
CFSs expression, moreover ERFSs are expressed in regions enriched 
in replication origins and coding regions.  
ERFSs activate a different damage signaling response pathway: 
immunofluorescence assays against γ-H2AX, the phosphorylated 
H2AX histone variant, a marker for dsDNA damaged regions, showed 
that ERFSs are enriched for this marker, whereas CFSs are not (Seo et 
al., 2013).  
Finally, it has to be said that there are some similarities between the 
two classes, in fact they are both enriched with CpG islands 
(Mortusewicz et al., 2013), this implies that more studies must be 
conducted on both classes in order to further know the characteristics 
and the similarities between these regions. 
 
Another observation made to explain the genomic instability observed 
within fragile regions is about the angle of twist on both common and 
rare fragile sites. The angle of twist is the angle between the reference 
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plane of a base couple before twisting, and the same plane after 
twisting and it is not always the same between the nucleotides: it is 
dependent upon nucleotides sequence and it is important in the 
determination of the stacking strength within the double helix.  
The FlexStab software is made to analyze the nucleotides’ angle of 
twist and the stacking in the fragile regions; the software on FRA7H 
(7q32.3) fragile region shows that many flexible regions are present, 
named “flexibility peaks” (Mishmar, 1998; Mishmar et al., 1999), the 
same thing has been found on CFSs FRA2G (2q31), FRA3B (3p14.2), 
FRAXB (Xp22.31), FRA7E (7q21.2) and  FRA16D (16q23.2) 
(Lukusa and Fryns, 2008). This is informing on the fact that even if 
CFSs are not characterized by nucleotides expansion as in RFSs, all 
the FSs are characterized by high rate of AT rich sequences in which 
the fragility must be found. In fact, it has been demonstrated, that the 
flexible sequences are enriched in AT repetitions that have a similar 
outcome to AT rich  minisatellites in terms of fragility responsible for 
the fragility of FRA16B and FRA10B RFSs; these sequences can form 
hairpins or cruciform-like secondary structures that could cause the 
replicative fork progression stall in order to resolve them, promoting 
genomic instability and the fragile sites expression (Zlotorynski et al., 
2003), or even the activation of checkpoint mechanisms that prevent 
the mitosis entry as the worst outcome. 
 
The fragility of FSs could be explained by distinctive sequences, 
visible as gaps or breaks on chromosomes and, by removing them, the 
genomic instability can be prevented. In fact, studies on tumor cell 
lines seem to offer a confirmation to this hypothesis; by deleting 500 
kb of DNA in FRAXB fragile site the fragility has been totally 
removed (Arlt et al., 2002). However, subsequent studies on hybrid 
cells containing chromosome 3 with large deletion on FRA3B fragile 
regions, did not give the same results in terms of reducing the fragility 
(Corbin et al., 2002). Recent studies on somatic hybrid cells with a 
deletion that spans from 200 to 600 kb in FRA3B, removing many 
flexibility peaks, demonstrated a reduction in fragility, not a complete 
eradication. 
So, the fragile sites instability could be a characteristic of regions 
delimitating the fragile regions rather than a feature of the fragile site 
itself. 
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The replication origins in Common Fragile Sites expression. 
DNA replication allows transmission of genetic material from an 
offspring to another when cell division occurs. In this process 
replication origins are extremely important; complementary double 
strands are separated, and bidirectional replication occurs. 
In mammals, replication must be fast to replicate correctly all the 
genomic material, at least 30,000 to 50,000 replication origins are 
activated in each cell cycle; this value exceeds the number of origins 
effectively activated during DNA replication, in fact, it is known that 
not all replication origins are simultaneously activated, but follow an 
accurate timing related to several factors such as cellular type or the 
healthy state of the cell (Huberman and Riggs, 1996). 
The characteristics of DNA’s replication origins can be briefly 
summarized (figure 5) analyzing them at different levels.  
Starting from a sequence point of view, two AT-rich regions are 
present, known as DUE (DNA Unwinding Elements) in which DNA is 
more easily unwinded, given to the presence of two hydrogen bonds 
connecting the AT bases: from here, presumably, replication starts; 
CpG islands are present too, helping double helix unwinding.  
From a structural point of view cruciform structure and loops 
formation have been described as able to alter fork progression speed. 
At chromatin level, nucleosome-free regions, histone acetylation and 
DNase-sensitive sites have been seen, but their direct participation in 
origin recognition or chromatin organization for transcription is 
sometimes difficult to estimate. The possible links between 
transcription factors with replication origin recognition have been 
described but evidences for their direct interactions remain scarce. 
Figure 5. Structural characteristics of DNA replication origins. The figure shows 
the characteristics of DNA replication origins observed within eukaryotes; many of 
these characteristics have been described following the metazoan replication origins 
but they are not shared by all origins (Méchali, 2010). 
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Not all replication origins in the genome are simultaneously activated 
because their activation depends on many factors. First of all, 
replication origins are activated in a very precise moment of S phase, 
this timing permits a temporal classification of replication origins in 
flexible, dormant (or inactive) and constitutive, based on when the 
replicative helicases (MCM) are assembled on pre-Replicative 
Complex (pre-RC). The pre-RC is a multiprotein complex formed on 
replication origins during DNA replication initial moments, it is 
fundamental for the replication starting process; it is composed of six 
ORC proteins (ORC 1-6), Cdc6, Cdt1 and the six proteins MCM 
(MCM2-7) (Yekezare et al., 2013). 
Although not all replication origins are activated, they are activated as 
fast as possible under particular conditions that could change S phase 
state; changes able to interfere with cells’ internal state leading to 
replication origins activation can be endogenous or exogenous: DNA 
damage for example or changes in growth condition of cell itself 
(Gilbert 2007). 
As mentioned before, three classes of replication origins can be 
described: flexible, dormant (or inactive) and constitutive. 
The constitutive are used in each DNA replication and are the same in 
every cell type even if they represent the minority among DNA 
replication origins. 
The flexibles are activated stochastically at every cell cycle in different 
cells, their presence could also be explained by the presence of a 50 
kb “initiation zone” in which is possible to find many replication 
origins activated indifferently (Mesner et al., 2003). The resulting 
pattern will reflect the sum of all individual situations and the 
stochastic nature of origin activation in this locus. If some origins are 
deleted, others nearby become more active or more efficient, reflecting 
a large choice of origins (Mesner et al., 2003; Kalejta et al., 1998). An 
explanation to the existence of flexible origins could be that in every 
cell, proteins responsible for replication to start are limiting and cannot 
bind every replication origin upon DNA, this will bring to the 
activation of the solely origins bonded by all molecular component 
useful to replication firing. Lastly, they could be easily activated by 
favorable chromatin domain in which origins are localized making 
their activation advantageous for replication to start, this has been 
observed in sub-telomeric regions where many replication origins are 
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located, and it is well known that these regions are rich in 
heterochromatin structurally complex compared to other regions 
(Hayashi et al., 2007). 
Inactive or dormant replication origins are potential origins not 
activated in normal condition but could been potentially fired 
following stressful condition or specific cell signals.  
 
 
The paucity of replication origins and Genomic Instability. 
Many fragile sites contain large genomic regions in which replication 
origins activation is not efficient, this seems to be one of the main 
causes of late DNA replication and non-replicated regions during 
mitosis. This late replication timing could be due to the number of 
replication origins in fragile regions and surrounding area. 
This has been extensively studied in lymphocytes, particularly in 
FRA3B, the most expressed human lymphocytes CFS. 
Replication timing along FRA3B is so reduced that replication 
completion happens only in late G2 in which more than 10% of fragile 
sites is not replicated (Le Beau et al., 1998; Wang et al., 1999). 
Analysis of fork progression speed without stressing condition 
between FRA3B and the rest of the genome shows no significant 
differences, similarly, when cells are treated with stressing agents such 
as APH, fork progression’s speed is drastically reduced but, again, 
there are no significant differences between FRA3B and genome. The 
differences appeared when FRA3B replication origins were identified 
with DNA combing technique, the presence of a 700 kb long region 
defined core within the FHIT (Fragile Histidine Triad Protein) gene 
lacking in replication origins and coincident with the most fragile 
region in FRAB can be identified.  
When in normal condition, the replication forks delimitating core 
region covers long distances before ending replication (figure 6a). If 
stressing agents like APH are present, replication forks activated in 
core regions are lower than non-treated cells, as well as replicative 
termination events, the last is a clear index of a defect in replication 
completion (figure 6b) (Letessier et al., 2011). 
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Studies conducted comparing FRA3B expression in different cell 
types show a tissue-specificity in fragility that can impact the 
percentage of fragile sites expression and it is subject to the number of 
active replication origins, these findings suggest a role of replication 
origins in fragility along with nucleotide sequence. 
From comparison of FRA3B expression between lymphocytes and 
two type of fibroblasts, MRC-5 and BJ (fibroblasts from fetal lung 
epithelium and primary epidermis fibroblasts respectively), difference 
of FRA3B expression is really marked with the highest to be found in 
lymphocytes. This is explicated by different number of active 
replication origins found in core flanking regions, showing a tissue-
specificity already in DNA replication; in fibroblast it is possible to 
find a higher number of replication origins flanking core region that, 
in stressful condition by APH addition are much more activated than 
in the same lymphocyte’s region, yielding to replication completion 
before mitosis, explaining the lower presence of breaks in fibroblast 
compared to lymphocytes (figure 6). 
This has been observed also in another CFS, FRA6E, in which a 500 
kb long region delimitating central portion of PARK2 (Parkinson 
Protein 2) gene shows few replication origins and analysis of 
replication fork progression’s speed gave results similar to FRA3B 
Figure 6. Fragile Sites and replication. Schematic representation of the core 
region replication in human FRA3B lymphocytes (left) and fibroblasts (right). 
The cell cycle phases are symbolized, the orange axes delimitate the core region. 
The upper images show normal conditions, the lower one shows the replication 
in stressful condition APH-induced (Debatisse et al., 2012).  
Lymphocytes Fibroblasts 
a 
b
b 
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and FHIT gene; dissimilarities were given by intrinsic variances of the 
two fragile sites like number of core’s replication origins responsible 
for both fragile regions fragility, FRA3B, in fact, shows a breaks 
percentage 5 times higher than FRA6E since the former contains less 
core’s replication origins (Mrasek et al., 2010). 
What has been said strengthens the idea that regions in which 
replicative forks cover long distances are more subjected to replicative 
fork progression slowing down, moreover, replication origins paucity 
has an important role in fragile sites’ instability indicating a tissue-
specificity in presence of active replication origins (Masai et al., 
2010). 
Regarding replication upon CFSs, a recent evidence shows the role of 
replicative polymerases able to switch with stalled specialized DNA 
polymerase δ; using an in vitro model of lagging strand replication and 
DNA template sequences from two different fragile sites, it has been 
demonstrated that either Pol η or κ, members of the Y-family and 
extensively studied for their role during DNA lesions, are capable of 
rescuing a pol δ stalled at repetitive non-B structure by performing 
synthesis on molecules initially extended, then stalled, by Pol δ within 
the CFS repeats instead of initiating synthesis on unextended 
molecules (Barnes et al., 2017). For CFS region that uses a single 
origin/replication fork during normal conditions may lack a 
compensatory fork during replication stress conditions (Le Tallec et 
al., 2011; Letessier et al., 2011). When this is the case, fork restart 
mechanisms that engage specialized DNA polymerases such as Pols 
η, κ, and ζ would become indispensable for maintaining CFS stability. 
 
 
Fragile Sites and Transcription. 
Many Fragile Sites colocalize within large genes (McAvoy et al., 
2007), these large genes have many molecular characteristics in 
common with regions defined as “fragile”, in fact they are often 
localized in late replicating domains or in AT-rich domains and those 
elements could promote genomic instability (Durkin et al., 2007).  
Regarding the transcription of these large genes’, it has been 
demonstrated that could take more than one cell cycle to be completed 
leading to simultaneous transcription and replication: the two 
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molecular machineries could collide leading to DNA breaks, that is 
why in eukaryotes replication and transcription are two temporally 
well separated events.  
Recent studies demonstrated that upon transcription of genes larger 
than 800 kb the completion goes for a second cell cycle event affecting 
also part of S phase, this delay is also due to large genes’ transcription 
which starts in late G2 phase, if not even M phase. 
Instability observed within these large genes is mainly due to R-loops; 
the R-loops are RNA:DNA hybrids that form when nascent mRNA 
strand binds complementary ssDNA resulting from double helix 
denaturation upon replicative fork progression; this phenomena is 
possible only if replicative and transcriptional machinery are close to 
each other. As said before, a large gene is transcribed in G2-M phase 
and the transcription is completed when RNA Pol II reaches the 
termination site, when nascent pre-mRNA strand binds to mitotic 
chromosomes, regions in which non-condensed chromatin could arise 
visible as CFSs on metaphase chromosomes. Moreover, when pre-
mRNA processing is impaired, R-loops are formed and they are 
among the primary cause of replicative fork progression stall and of 
double strands breaks of these regions (Gomez-Gonzalez et al., 2009; 
Tuduri et al., 2009). When DNA replication progression is impaired, 
for example upon APH addition, breaks depending on R-loops gather 
near large genes, so RNA:DNA hybrids are formed when transcription 
machinery collides with slowed-down or blocked replicative 
machinery (figure 7).  
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Topoisomerase I (TOP I) has a major role in R-loops resolving. TOP 
I is an essential enzyme for replication, functioning cutting one of the 
two DNA strands, relaxing and annealing it when supercoiled DNA 
forms: if not resolved, breaks upon double strand helix could arise 
impairing normal replicative fork progression (Wang 2002); when 
TOP I is absent, chromosomal breaks, both in fragile and non-fragile 
regions, arise even in cells in which replication is not impaired (Tuduri 
et al., 2009). So, instability observed within CFSs could come from 
slow replication or from TOP I loss or malfunctioning (Helmrich et 
al., 2011). 
 
Figure 7. Collision between replicative and transcriptional machineries bring 
to R-loops formation. Large genes begin to be transcribed in G2 or M phase, when 
the machinery meets a stressed replicative fork R-loops are formed, bringing to 
CFSs formation. The right image shows the current model in large genes’ R-loops 
formation, at left normal condition upon silent genes are shown (Helmrich et al., 
2011). 
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AIM OF THE RESEARCH 
 
Common Fragile Sites (CFSs) are important elements in promoting 
genomic instability in human genome.  
They are characterized by impairments in replication due to AT-rich 
nucleotide sequences that tend to form secondary structures and by the 
number of active (or activable) replication origins responsible for the 
replication of the entire region: all these characteristics make the 
replication timing of CFSs to be late or delayed. Many pathologies, 
including different type of tumors and neurodegenerative diseases in 
particular, can be generated by aberrations involving breaks at CFSs 
regions.  
Replication timing can vary among different cell types mostly because 
of the number of active replication origins so, given the connection 
between CFSs and replication, I searched if a connection between 
tissue specificity and CFSs expression was present. In fact, historically 
speaking, CFSs have been discovered and extensively studied in 
human lymphocytes, mostly because of the simplicity in eliciting them 
in this cell type, giving the possibility to understand many of the 
molecular and structural characteristics of the CFSs. An explanation 
to the tissue specificity of CFSs expression will be helpful in 
understanding the correlation between their localization and 
chromosomal rearrangements in tumor and diseases from different cell 
types. 
I started the analysis from two fibroblast cell lines, both from fetal lung 
epithelium, MRC-5 and IMR-90. Comparing the CFSs induced by 
APH in fibroblasts with the most expressed CFSs in lymphocytes, 
among the others, were 1p31.1 on short arm of chromosome 1 and 
3q13.3 on long arm of chromosome 3, exclusively expressed in 
fibroblasts. 
Their molecular characterization was performed using BAC clones 
and fluorescent in situ hybridization (FISH) in order to define their 
exact cytogenetic localization. Next, the database consulting was used 
to characterize the nucleotides composition, such as AT/GC 
percentage, and the relative content in LINEs, Alu, miRNAs and LTR 
elements to see if their presence could be involved in promoting 
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fragility. The same elements were confronted with non-fragile regions 
(NFRA) and standard genome sequences with similar GC content.  
Even the presence of actively transcribing genes was investigated. 
 
In the second part of my work I analyzed the CFSs replication in order 
to investigate the relationship between DNA replication timing and 
fragility. 
Using FISH combined with IF anti-BrdU on interphasic nuclei, it was 
possible to observe their replicative state using fragile regions from 
lymphocytes on fibroblasts as controls and it was possible to analyze 
their peculiarities in replication timing confronting fibroblasts CFSs 
replication in lymphocytes in which these regions are non-fragile. 
 
In the last part of my work I searched on Mitelman database if these 
fragile regions were subjected to chromosomal instability in different 
type of tumors and diseases. 
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RESULTS AND DISCUSSION 
 
We induced CFSs in both MRC-5 and IMR-90 fibroblast cell lines 
cultured with medium added with APH to induce replicative stress. 
The breaks have been identified with Giemsa staining, recognized and 
localized cytogenetically with R-banding (figure 8).  
 
 
The putative CFSs identified are present in fibroblasts and not in 
lymphocytes apart from FRA3B and FRA16D, the two most expressed 
CFSs in human genome.  
To be classified as a CFS, a break must be expressed with a frequency 
higher than 3%.  
In our fibroblast cell lines, we chose to analyze the following putative 
CFSs: 
 
- 1p31.1 located on chromosome 1 with a 19% frequency of 
expression in MRC-5 and 5% frequency of expression in IMR-
90; 
- 3q13.3 located on chromosome 3 with an 8% frequency of 
expression in MRC-5 and 27% frequency of expression in 
IMR-90. 
 
 
Figure 8. IMR-90 metaphase stained with Giemsa (left) and CMA3 (right). The 
arrows show breaks on chromosomes 7 (7q11.2; upper left) and 3 (3q13.3; down). 
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The histogram below shows the most expressed breaks in both 
fibroblast cell lines (figure 9). 
 
 
 
The results obtained show a different frequency of expression for the 
same CFS in both fibroblast cell lines used for our analysis.  
It is well known that different individuals among the same population 
show variations in frequency for the expression of the same fragile 
site. In this specific case, these data may be explained by differences 
in gender, developmental stage and also, possibly, by a different 
transcriptional activity and replication profile in both cell lines. 
 
 
 
 
 
 
 
Figure 9. CFSs expression in fibroblasts. The histogram shows all the breaks 
expressed in both MRC-5 and IMR-90 cell lines; the breaks with frequency lower than 
3% have not been considered. 
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Molecular characterization of Fragile Sites. 
 
1p31.1 Fragile Region. 
The 1p31.1 is located on the short arm of chromosome 1 for about 4 
Mb.  
Figure 10. Schematic representation of 1p31.3 fragile region. The BAC clones 
used for the characterization, along with some genes, are shown (adapted from 
www.ncbi.nlm.nih.gov/mapview). 
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The FISH signals with the two chosen probes (distal RP11-316C12; 
proximal RP11-297N6) localize the fragile region in a G-band (figure 
10).  
 
 
 
 
 
 
 
The Genome Data Viewer NCBI database (build 37) locates 52 
different genes along the fragile region (figure 10), many of these 
genes regulate important cellular features; a long non-coding RNA is 
also present (LINC01360), and a miR (miR186) known to function as 
tumor suppressor in many solid tumors can also be found.  
It is known the role of large genes in promoting fragile sites’ instability 
(Smith et al., 2007) due to R-loops formation; in the most fragile 
region is located an 886 kb long gene, NEGR1 (Neuronal Growth 
Regulator 1). This gene is highly expressed in brain and is involved in 
protein metabolism pathways and post-translational modification-
synthesis of GPI-anchored proteins; an important paralog of this gene 
is LSAMP, located in 3q13.3, the other fragile region analyzed in 
fibroblasts. 
Using Replication Domain database (www.replicationdomain.org), 
the replicative state of the gene was analyzed (figure 12); the 
replication pattern shows a late replication timing. In fact, this is in 
concordance with studies which hypothesize that large genes replicate 
late (Helmrich et al., 2011) and have a replication origin scarcity and, 
as a consequence, are particularly sensitive to replication stress 
because stalling of converging forks cannot be rescued by dormant 
Figure 11. 1p31.1 fragile region. On the left, break on short arm of chromosome 
1 (1p31.1) is identified with Giemsa staining; in the central figure the same 
chromosome is visualized with DAPI; in the right figure distal and proximal probes 
are localized, in the same chromosome, through FISH experiment. 
Distal 
Proximal 
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origins, preventing these regions from completing replication before 
entry into mitosis (Oestergaard and Lisby, 2017). 
The fact that this large gene shows a late replication timing suggests 
that could promote genomic instability by forming, probably, R-loops. 
For molecular characterization www.repeatmasker.org public 
database was used to analyze the sequence in order to find 
characteristics to explain the fragility; AT content, LINEs, Alu, LTRs 
Figure 12. Schematic representation of region 71,402,942 - 72,282,594 bp of 
chromosome 1 where NEGR1 can be found; the graph shows the late replication 
timing of NEGR1 gene (from replicationdomain.org). 
Figure 13. The histogram (left) shows the percentage of Alu, miRNAs, LINE1-2, 
LTR elements along the 1p31.1 region; on the right GC-AT content is shown. 
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and miRNAs have been investigated for their role in promoting 
genomic plasticity in higher eukaryotes (figure 13; left).  
The sequence analysis was done by examining all the sequences along 
the fragile region, moving from telomeric to centromeric extremity. 
The repeatmasker.org database results showed that this region is not 
enriched for Alu, miRNAs and LINE2 elements but a high percentage 
of LINE 1 elements (23,5%) is observed; this enrichment finds 
validation in literature data since LINEs elements are preferentially 
transposed in AT rich regions and are AT-rich themselves, in 
concordance with high levels of AT (64%) in 1p31.1 fragile site, 
which is a very high value (figure 13; right).  
The sequence analysis is then compared with non-fragile regions 
(NFRA) and standard genomic sequences with similar AT content 
(Smit 1999), to investigate the presence of any difference between 
different regions. The comparisons showed no significative 
differences between 1p31.1 fragile region, NFRA and genomic 
sequences (figure 14), apart from slightly enrichment in LINE1, LTR 
and miRNAs.  
Figure 14. Sequence analysis and comparison between fragile region (1p31.1), non-
fragile region (NFRA) and standard Genomic Sequence (Human Genome).  
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The results suggest a marginal role of these elements in promoting 
genomic instability of 1p31.1 fragile site, in concordance with 
literature data in which the fragile regions are not enriched of these 
elements, even in other tissues.  
 
 
3q13.3 Fragile Region. 
Figure 15. Schematic representation of 3q13.3 fragile region; the BACs used for 
characterization are shown along with some genes (adapted from 
www.ncbi.nlm.nih.gov/mapview). 
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The fragile region on long arm of chromosome 3 spans for more than 
4 Mb in 3q13.3 chromosomal region; the probes chosen for FISH 
analysis (distal RP11-324H4; proximal RP11-305I9) localize 3q13.3 
between  a G and a R-band and could partially explain the high level 
of expression of this fragile site, in fact it is known that instability 
associated with FSs is higher at AT-GC interface (G/R-bands) because 
of a greater difference in corresponding twist angles (Mishmar et al., 
1999). 
The database analysis revealed the presence of 64 genes and two of 
them localize in the most fragile region; LSAMP (Limbic System-
Associated Membrane Protein) and ARHGAP31 (Rho GTPase 
activating protein 31) are 1,33 Mb and 126 kbs long respectively and 
could be involved in fragility of 3q13.3 fragile site. miRNAs and long 
non-coding RNAs can be found as well (figure 15). 
LSAMP, mapping in the fragile site proximal region, encodes for a 
member of immunoglobulin LAMP, OBCAM and neurotrimin 
(IgLON) family of proteins, contributes to the guidance of developing 
axons and remodeling of mature circuits in the limbic system. Known 
to function as tumor suppressor, its expression is high in brain, bladder 
and prostate. The replication timing analysis showed a delayed 
replication (figure 16), that could promote fragility by forming R-
loops with mechanisms explained before.  
 
Figure 16. Replication timing analysis of LSAMP gene; region from 115,802,363 - 
117,139,389 bp shows LSAMP gene replication timing analysis (from 
replicationdomain.org). 
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Since of its 1,33 Mb length, LSAMP gene could promote instability of 
3q13.3 region; supportive to this hypothesis is replication timing 
analysis of the region. Since its late replication timing, and its high 
expression in lung tissue, this could explain the fragile region’s high 
expression frequency by promoting the formation of R-loops as 
consequence of transcriptional and replicative machineries encounter 
(Helmrich et al., 2011), and by lacking activable replication origins to 
complete replication timing, which is a similar outcome hypothesized 
for NEGR1 gene on chromosome 1. 
ARHGAP31 is a GTPase Activating Protein coding gene located in 
fragile site distal region; the encoded protein is a GAP shown to 
regulate two GTPases involved in protein trafficking and cell growth, 
required for cell spreading, polarized lamellipodia formation and cell 
migration. Chromosomal aberrations in this gene cause the Adams-
Oliver Syndrome with abnormality in skin development and 
malformations of the limb among the primary features (Isrie et al., 
2014). The gene dimensions could not promote the region genomic 
instability, but since its early replication timing (figure 17) and its high 
expression in lung tissue, encounters between replicative and 
transcriptional machineries could happen. 
 
Figure 17. Replication timing analysis of ARHGAP31 gene (region 119,294,289- 
119,420,714 bp) show an early replication timing of the region that could promote 
fragile site expression (from replicationdomain.org). 
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Next, there is the analysis of elements characterizing the region, with 
www.repeatmasker.org public database: AT content, LINEs, Alu, 
LTRs and miRNAs were analyzed.  
 
Figure 18. The histogram (left) shows the percentage of Alus, miRNAs, LINE1-
2, LTR elements along the 3q13.3 region; on the right GC-AT content is shown 
Figure 19. Sequence analysis and comparison between fragile region (3q13.3), non-
fragile region (NFRA) and standard Genomic Sequence (Human Genome).  
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Again, the region is not enriched for these elements apart from LINE1 
as shown in figure 18. The repetitive and regulative elements are not 
responsible for instability associated within this region. 
The comparison between the fragile region, NFRA and standard 
genomic sequences, again showed no significant differences (figure 
19) confirming the previous hypothesis. 
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Replication Timing analysis of Fragile Regions. 
An important characteristic of CFSs is altered replication timing. To 
characterize putative CFSs’ replication timing, analysis has been 
conducted on interphasic nuclei combining FISH experiments with 
immunofluorescence against BrdU to identify active replicating cells. 
FISH probes chosen by online genomic database screening, delimitate 
putative CFSs edges: one is proximal to the centromere and the other 
one is distal from the centromere as shown in figure 20 on 
chromosome 1 CFSs. 
 
Five temporal S-phase stages, from early (I stage) to late (V stage), 
can be identified analyzing the pattern of BrdU incorporation in 
replicating cells (figure 21).  
 
Figure 21. Five S-phase substages are shown with immunofluorescence anti-BrdU 
on interphasic nuclei, from the earliest (phase I, a) to the latest (V, e); red spots show 
FISH signals (Pelliccia et al., 2010). 
Figure 20. The figure shows 1p31.1 fragile region. On the left, break on short arm 
of chromosome 1 (black arrow) is identified with Giemsa staining; in the central 
figure the same chromosome is visualized with DAPI; on the right, distal (red spot) 
and proximal probes (yellow spot) are localized, in the same chromosome, through 
FISH experiment. 
 
10 μm 
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FISH was used to point out the replication timing of analyzed fragile 
regions; it makes possible the discrimination between non-replicated 
allele (S, single spot) from replicated one (D, double spot); the 
asynchronous alleles are visualized as double and single spot (DS) in 
each chromosome homologous (figure 22). 
In each experimental protocol, two probes, specific for each fragile 
region, have been analyzed simultaneously with FISH experiments, 
the combination of FISH technique (S spot or D spot) with the BrdU-
IF allows the recognition of the S phase in which each genomic region 
is replicating or not; for each probe at least 500 S-phase nuclei have 
been analyzed in each cell line and the signal obtained was associated 
with corresponding S-phase stage. 
Replication timing pattern of CFSs in fibroblasts has been confronted, 
for the same region, in lymphocytes from peripheral blood, in which 
the same region is non-fragile. The data obtained from fibroblasts’ 
fragile regions in lymphocytes were used for the replication timing 
analysis of both fibroblast tissues. 
The experiments were conducted in duplicate with and without APH 
to analyze replication timing differences in normal and stressful 
condition in each putative CFS.  
 
S 
D 
Figure 22. Double and Single spots on interphasic nuclei. Fluorescence in situ 
Hybridization’s spots (left) are visible as double (D) and single (S) spots on 
asynchronous alleles; on the right, same nucleus is visualized with 
immunofluorescence against BrdU. A stage IV of S-phase is shown. 
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Replication Timing analysis of 1p31.1 Fragile Site. 
 
- Normal conditions: 
 
 
Starting with replication timing analysis of 1p31.3 fragile site, the two 
probes in MRC-5 fibroblasts and lymphocytes (proximal RP11-
297N6; distal RP11-316C12) start early in phase I, with few 
differences in replicated alleles percentage (5% - 13% of D spots), 
apart from proximal probe in lymphocytes, in which no D spots can 
be found. Moving forward along replication timing the differences 
appear significative.  
In lymphocytes, the replication follows a linear trend, with 52% of 
alleles already replicated in phase III in both regions until they arrive 
at the end of phase V with 100% of replicated alleles, indicating a 
normal replication timing, since they are non-fragile regions in 
lymphocytes.  
In MRC-5, proximal region starts early in phase I (8% of D spot) and 
double alleles percentage rises until phase III in which 55% of alleles 
are already replicated, although replication slows down and arrives in 
phase V with 25% of non-replicated alleles. The replication trend in 
MRC-5 distal probes is even slower, it starts early in phase I (13% of 
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D spot), until a stall that lasts from phase II to phase IV is found, and 
replicated alleles do not increase (31%, 33% and 39% in phase II, III 
and IV respectively); the trend is confirmed from arrival in phase V 
with 75% of replicated alleles, the same percentage as proximal probe.  
 
 
Analyzing the replication timing in IMR-90 fibroblast cell line in 
normal condition the trend is quite regular, apart differences in 
replicated alleles’ timing. In fact, the IMR-90’s probes start to be 
replicated earlier than lymphocytes’ and MRC-5’s ones; fibroblasts’ 
proximal and distal probes have 38% and 25% of D-spots in phase I 
respectively, while the same in lymphocytes are later replicating, the 
distal one is not even replicated yet, while the proximal probe has 5% 
of D-spots in phase I.  
Continuing the analysis, fibroblasts encounter a stall that lasts from 
phase II until phase IV and this stall could be explained with the fact 
that chromatin undergoes different conformational changes in order to 
let the replication  proceed from earlier to later stages; they arrive at 
the end of the S-phase with almost all replicated alleles (94% form 
proximal and 86% for distal probes).  
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The remaining not replicated alleles are not expressed as breaks, since 
they could be repaired in G2 phase or even in mitosis.  
Lymphocytes replicate all of their alleles at S-phase ending. 
 
 
- Stressful conditions: 
 
In stressful condition replication timing appears quite regular in both 
cell lines. 
 
Probes in lymphocytes replicate early in phase I (18% of D spot) and 
the proximal probe arrives with totally replicated alleles; the distal 
probe shows a similar trend but it arrives in phase V with 25% of non-
replicated alleles, indicating that this region, even if non-fragile in 
lymphocytes, shows replication’s impairments.  
In MRC-5, both regions start later than lymphocytes to be replicated, 
with no replicated alleles in phase I; an increase in replication is found 
only until phase III (51% of replicated alleles in both), then both 
proximal and distal regions arrive with few replicated alleles in phase 
V, with 67% and 75% of D spots respectively. 
Analyzing the replication trend in both cell lines it is clear that there is 
an impediment in fork progression in phase III (55% of replicated 
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alleles in both cell lines in the two regions) probably given by 
structural characteristics, like nucleotide composition or sequences 
incline to form secondary structure, APH presence makes these 
characteristics more visible, indicating that this region is difficult to 
replicate even in tissue not expressing the fragile site.  
 
In stressful condition, replicative irregular trend reflects the region’s 
fragile nature in both cell lines. Even in this case fragile regions 
replicate early, with 50% of alleles already replicated in phase I, even 
lymphocytes are early in starting the replication (17% of D-spots for 
proximal and 18% for distal). The trend is quite linear, the D-signals 
increase in both regions and in proximal reach 100%, while the distal 
one is more problematic arriving in phase V with 25% of non-
replicated alleles.  
In fibroblasts, distal probe increases replication timing but after phase 
III (75% of D-spots) replication’s speed decreases  arriving in phase 
V with 35% of alleles non-replicated; the proximal probe has a similar 
outcome, it decreases in phase II (38%) after which there is a sharp 
increase and a stasis from phase III (68% D-spots) until phase IV (75% 
D-spots) in which replicated alleles do not reache 100% (75% of D-
spots in phase V). The stasis observed in the last phases could be 
explained with the fact that all replication origins have already been 
activated in earlier phases. 
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Replication timing analysis of 3q13.3 fragile site. 
 
- Normal conditions 
 
 
Replication timing of 3q13.3 in normal condition shows an almost 
linear trend. Both regions (proximal RP11-324H4 and distal RP11-
305I9) in both cell lines start replication in phase I with 4% of 
replicated alleles in MRC-5 and lymphocytes’ proximal regions, and 
8% of D spots for MRC-5 distal region, apart from lymphocytes’ distal 
probe (no D spots detectable in phase I). From phase I onward, 
replicated alleles increase until phase IV for both distal probes and 
MRC-5 proximal (58% and 61% for the first two, 69% for the latter); 
lymphocytes’ proximal probe shows an irregular trend from phase III 
onward, but it ends the replication with 100% of replicated alleles, as 
in the distal one. 
Both MRC-5 regions arrive in phase V with non-replicated alleles, 
25% for the distal probe, and a 50% of alleles to be replicated in 
proximal one. MRC-5’s trend reflects the nature of FSs fragility, in 
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fact they represent regions with structural peculiarities, even in non-
stressful condition, as shown for MRC-5’s replication. 
 
 
Replication timing of 3q13.3 fragile site is quite linear in IMR-90, 
apart from proximal probe, which is early replicating (57% of D-spots 
in phase I); the other regions proceed as a block in a linear trend 
mostly: they start from around 0-4% and increase linearly until phase 
III. From phase III onwards IMR-90 increase until phase IV (80% of 
D-spots) afterwards a decrease in phase V can be observed with only 
61% of replicated alleles. The other fibroblasts’ region replicates early 
with a regular trend which remains regular, ending with 83% of 
replicated alleles.  
The lymphocytes’ regions arrive in phase V with all of their alleles 
replicated. 
 
 
 
 
 
- Stressful conditions 
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Replication trend in stressful condition is much more irregular.  
The two proximal probes show a similar trend from phase I until phase 
III where a stall in replication can be visualized (54% of replicated 
alleles).  
Distal probes show the most irregular trend. MRC-5’s probe starts 
quite early in phase I with already 30% of D signals followed by a 
sharp decrease in phase II and a rising until phase V. The lymphocytes’ 
one instead is a late replicating region in this tissue: it starts to be 
replicated only after phase II but it arrives at the end of S phase with 
100% of replicated alleles. 
Three probes out of four arrive in phase V with non-replicated alleles: 
lymphocytes’ and MRC-5 proximal with 75% and 70% of replicated 
alleles, MRC-5 distal with 67% of D spots. Only lymphocytes’ distal 
probe arrives at phase V with 100% of replicated alleles. 
The typical trend showed by all regions, and in lymphocytes in 
particular in which these regions should be non-fragile, is concordant 
with previous FS’s analysis results: these regions show difficult 
replication even in other tissue, suggesting structural impediment for 
efficient replicative fork progression. 
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This replication is quite peculiar in every region for both cell lines. 
Starting with fibroblasts, both regions are quite early in replication 
starting around 40% of replicated alleles in phase I, in phase II distal 
one decreases (30% of D-spots), after which the trend is linear until of 
S-phase’s termination, in which non-replicated alleles are over 56%; 
proximal one, after a slight increase in phase II (64% of D-spots), 
encounters a stall which lasts until phase IV and the replicated alleles 
do not increase significantly (69%). After that, alleles decrease, and 
they end S-phase with over 50% of non-replicated alleles. The stasis 
observed in II-IV phases could again be explained with the fact that 
all replication  origins have already been activated in previous phases, 
leaving regions not completely replicated in last phases. 
The lymphocytes’ replication is quite peculiar as shown in previous 
analysis for MRC-5. 
The tables summarize the results obtained from replication timing 
analysis in all cell lines in both conditions for both analyzed fragile 
regions. 
 
1p31.1 normal condition.  
Lymphocytes MRC-5 IMR-90 
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Canonical replication  
100% in V 
Distal: early but slow in II – 
IV, 75% in V 
   
Proximal: early and fast in II 
– III 
Slow in III – V (75%) 
Distal: early but slow in II – 
IV (74%); 86% in V 
 
Proximal: early but slow in II 
– IV (65%); 94% in V 
 
1p31.1 stressful condition.  
Lymphocytes MRC-5 IMR-90 
Early start compared to 
normal condition 
Distal: almost regular but 
75% in V 
 
Proximal: almost canonical 
100% in V 
Late start 
   
Distal: almost regular until V 
(75%)  
 
Proximal: canonical start until 
III; stasis until V (67%) 
Very early (50%) 
 
Distal: slow progression in III 
(75%); decrease in V (65%) 
 
Proximal: decrease in II, fast 
progression in III, slows in V 
(75%) 
 
 
3q13.3 normal condition.  
Lymphocytes MRC-5 IMR-90 
Almost linear progression 
100% in V 
Linear progression until IV 
 
Distal: regular until IV (65%) 
but 75% in V 
 
Proximal: regular until IV 
(58%) but decrease in V 
(50%) 
Peculiar trend for proximal 
 
Distal: regular until IV (80%) 
decrease in V (61%) 
 
Proximal: very early (57%); 
89% in V 
 
3q13.3 stressful conditions.  
Lymphocytes MRC-5 IMR-90 
Early start compared to 
normal condition 
 
Distal: problematic beginning 
but 100% in V 
 
Proximal: 10% in I; regular 
trend and stasis in III - IV 
Late start 
   
Distal: early start (30%), 
decrease in II and restart in V 
(70%)  
 
Proximal: late start and 
regular until III (54%) slows 
and 70% in V 
Very early (50%) 
 
Distal: early start (40%) drop 
in II and 44% in V 
 
 
Proximal: early start (40%); 
“problematic” trend in V 
(50%) 
 
 
Genomic Instability at 1p31.1 and 3q13.3 fragile regions. 
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In the last part of my work I searched, using online public databases, 
if both fragile regions were exposed to chromosomal instability in 
different type of tumors and diseases. Mitelman Database 
(https://cgap.nci.nih.gov/Chromosomes/Mitelman) of Chromosome 
Aberrations and Gene Fusions in Cancer relates chromosomal 
aberrations to tumor characteristics, based either on individual cases 
or associations, and has been used on 1p31.1 and 3q13.3 fragile 
regions; the results are shown in tables 1 and 2.  
As data show (table 1 and 2), both fragile regions are under severe 
chromosomal instability that causes different rearrangements in both 
solid and hematopoietic tumors in different cell types. 
In 3q13.3 region several genes are localized and two of them LSAMP 
and ARHGAP31 map at the boundaries of core region. Both of them 
are transcribed in both analyzed fibroblast cell lines and LSAMP is 
even a large gene showing a late replication timing, typical of large 
genes located in fragile regions; their transcription could explain the 
high frequency of expression in 3q13.3 region. 
The most important genes located in this region are even under gene 
mutations involved in different kind of psychiatric diseases and many 
types of tumors, since most of them are tumor suppressor genes such 
TUSC7, LSAMP and IGSF11. The same can be said for NEGR1 large 
gene on chromosome 1; mutations in this gene are involved in 
psychiatric disorders and poor outcomes in neuroblastoma. 
All these evidences seem to confirm the hypothesis that large genes 
localized within fragile regions are involved in chromosomal 
instability because most of them are transcribing, late replicating 
genes, most probably localized in regions with poor dormant origins 
unable to be activated upon stressful agents, moreover the genes 
located in these fragile regions are probably subjected to mutations 
themselves because of their localization in structural fragile regions. 
The genes and the structural characteristics found in these fragile 
regions, will need further investigations to better understand the 
connection between replication, transcription and structural 
organization of the chromatin in these regions of instability.
 Unbalanced chromosomal aberrations in 
solid tumors 
 
Unbalanced chromosomal aberrations in 
hematopoietic tumors 
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Balanced chromosomal aberrations in 
hematopoietic tumors 
 
Table 1. The tables show the chromosomal rearrangements in 1p31.1 fragile region 
involved in different type of solid and hematopoietic tumors (adaptation from 
Mitelman database; https://cgap.nci.nih.gov/Chromosomes/Mitelman). 
Balanced chromosomal aberrations in 
hematopoietic tumors 
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Unbalanced chromosomal aberrations in 
solid tumors 
 
Unbalanced chromosomal aberrations in 
solid tumors 
 
Balanced chromosomal aberrations in 
solid tumors 
 
Table 2. The tables show the chromosomal rearrangements in 3q13.3 fragile region 
involved in different type of solid and hematopoietic tumors (adaptation from 
Mitelman database; https://cgap.nci.nih.gov/Chromosomes/Mitelman).  
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CONCLUSIONS 
In this work different aspects of CFSs were investigated. 
The tissue specificity associated with CFSs was examined and 
confirmed: 1p31.1 and 3q13.3 are CFSs expressed in MRC-5 and 
IMR-90 fibroblast cell lines. The two fragile regions are among the 
most expressed breaks in both fibroblast cell lines and cannot be found 
in lymphocytes.  
Their molecular characterization was performed to confirm the nature 
of these breakages as CFS, they both have a percentage of expression 
higher than 3% and high AT percentage, typical characteristics found 
in CFSs. 
 
Sequence analysis shows the presence of many genes in both fragile 
regions and some of them are large genes, NEGR1 (886 kb) is located 
in the core region of 1p31.1, while LSAMP (1,33 Mb) is found at the 
boundary of 3q13.3 core region. It is known that large genes are late 
replicating and could promote chromosomal instability on CFS by R-
loops formation; using online public database we found a 
correspondence in both fragile regions between large gene and late 
replication timing, in fact they both replicate late, and this evidence 
could explain the high frequency of expression observed in both CFSs.  
Moreover, in 3q13.3 region ARHGAP31 gene (1,26 kb) is an early 
replicating gene and could promote the fragility by causing replicative 
and transcriptional machineries collision.  
 
Using online databases, characterization of repetitive and regulative 
elements was performed to search the causes of these CFSs instability; 
these elements are not different in percentage to those in non-fragile 
regions and in the rest of the genome, so they can be excluded, so far, 
from promoting fragility in 1p31.1 and 3q13.3.  
 
Knowing that non-canonical replication timing is among the main 
causes for CFSs instability within genome, their replication analysis 
was performed as well.  
The results show a typical trend of fragile regions, with alleles not 
completely replicated at the end of S-phase in both normal and 
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stressful conditions, moreover these regions, in a non-fragile 
background, displayed a non-canonical replication as showed from 
replication analysis in lymphocytes, suggesting the presence of 
structural peculiarities that impair replicative fork progression since 
these regions do not complete the replication of their alleles at the end 
of S-phase.  
These results suggest a prominent role of replication in promoting 
fragility in these regions. Further analysis will be performed to 
confirm the role of replication on both fragile regions. 
 
Finally, Mitelman database was used on 1p31.1 and 3q13.3 fragile 
regions to investigate if these regions were under chromosomal 
instability. The results showed a strong chromosomal instability in 
both regions analyzed, involved in solid and hematopoietic 
tumorigenesis.  
Another evidence of the connection between CFSs and genomic 
instability is that most of the genes localized in both regions are 
mutated in different diseases that go from tumors in different cell 
types, since most of them are tumor-suppressor genes, to psychiatric 
disorders. 
 
All these results suggest that both fragile regions are under a strong 
chromosomal instability and are involved in genesis of different type 
of disorders, further experiments will shed a new light on CFSs 
involvement in promoting genomic instability and diseases. 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
Cell lines. 
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For this work three cell lines have been used: two fibroblast cell lines, 
IMR-90 and MRC-5, and lymphocytes from peripheral blood. 
 
- Fibroblast IMR-90: from the lung epithelium of a 16-week 
female fetus, with normal karyotype. They are not 
immortalized; these cells can undergo trough 58 population 
doublings before entering replicative senescence. Their 
dividing potential, the virus susceptibility has extensively been 
studied, in fact they can be considered as an alternative to the 
WI-38 cell line. 
- Fibroblast MRC-5: similar to the former cell line; derive from 
the lung epithelium of 14 weeks old male fetus, with a normal 
karyotype; the cells are capable of 42 to 46 population 
doublings before the senescence onset. 
- Peripheral blood lymphocytes: at least 5 mL of blood from an 
adult normal individual are cultured with sodic heparin to 
avoid blood clotting. 
 
Lymphocyte cell culture. 
The lymphocytes have been obtained sampling 0.3 mL of peripheral 
blood of a male human healthy individual with a heparin prefilled 
syringe. Afterward 5 mL of specific suspension cell culture medium 
(RPMI 1640, Corning) supplemented with 10% of Fetal Bovine Serum 
(Gibco) and 1% of L - glutamine (Sigma) are added.  Addition of 0.15 
mL of phytohemagglutinin (PHA M - form, Gibco), allows T-cells 
activation. The cells are incubated at 37°C for 72 hours.  
In the last 24 hours, 0.4 μM of aphidicolin (Sigma-Aldrich) are added 
to allows the expression of fragile sites in the last part of the S phase. 
Afterward, the addition of 10 -4 M of colchicine (Sigma-Aldrich) for 2 
hours, allows the depolymerization of microtubules and mitotic 
spindle disassembly, hence the visualization of the metaphase 
chromosomes is accomplished. 
In order to study the replication timing, 10 μM bromodeoxyuridine are 
added (Sigma-Aldrich) in the last 20 minutes. 
 
Fibroblasts cell culture. 
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The cells, that come from N2 vapor phases, are rapidly thawed in a 
37°C water bath for a maximum of 2 minutes and then 5 mL of 10% 
FBS - 1% L-glutamine medium (MEM 1X, Gibco) are gradually 
added. Finally, the cells are incubated at 37° C with 5% CO2.  
In the last 20 - 22 hours, 0.4 μM of aphidicolin are added for fragile 
sites induction; 10 μM of bromodeoxyuridine are added in the last 20 
minutes for replication timing analysis studies. For metaphases 
spreads 10 -4 M of colchicine (Sigma-Aldrich) is added for 4 hours. 
 
Cytological samples from lymphocytes culture. 
To harvest the cells, the tubes are centrifuged at 2000 rpm for 4 
minutes; the addition of 0.0075 M of KCl hypotonic solution, for 7 
minutes, swells the nuclei.  
After a second centrifugation, Ibraimov solution is added (5% acetic 
acid - 3% methanol in distilled H2O) as a pre-fixation before the third 
centrifugation, they are followed by two subsequent washes with – 
20°C cold fixative (methanol – acetic acid 3:1) in order to dehydrate 
the chromosomes on the slide. 
The last centrifugation removes the fixative, the pellet is air dried 
before the samples’ preparation made by releasing few drops on an 
ice-cold glass slide. 
 
Cytological samples from fibroblasts culture. 
a) cytocentrifuges samples preparation. 
The medium is gently removed from the plate, the hypotonic 
buffer addition (10 mM Tris-HCl [pH 7.4], 40 mM glycerol, 
20 mM NaCl, 1.0 mM CaCl2, 0.5 mM MgCl2) for 15 minutes 
at 37°C allows detaching of mitotic cells; the cells are collected 
by pipetting hypotonic buffer several times. 
The buffer is centrifuged at 1800 rpm for 8 minutes and fixed 
in -20°C cold fixative (methanol – acetic acid 3:1) for 20 
minutes. 
 
b) Air drying samples preparation. 
The addition of 0.4 μM aphidicolin in the last 22 hours allows 
the induction of CFSs.  
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The medium is removed, after two subsequent washes in PBS 
(Phosphate Buffered Saline, Corning), the trypsin addition 
(0.05% trypsin, 0.53 mM EDTA, Gibco) for 8 minutes at 37°C, 
allows fibroblasts cells detachment.  
The cells collected with 10% FBS - 1% L-glutamine (MEM 
1X, Gibco) complete medium are centrifuged for 5 minutes at 
1200 rpm. The nuclei are swelled with 0.075 M KCl hypotonic 
solution for 6 minutes before a 1200 rpm centrifuge for 5 
minutes to remove solution. Two consequent 4 minutes 
centrifuges in -20°C cold fixative (methanol – acetic acid 3:1) 
at 1200 rpm leaves the pellet clean. The tubes are sets 
overnight at -20°C before slides preparation. 
The cells are pelleted by 1200 rpm 5 minutes centrifuge and 
afterwards dried under a fume hood for 15 minutes before 
adding few drops of -20°C cold fixative.  
Few drips of cells suspension are dropped on cold glass slides; 
the quality of the slides can be observed by phase-contrast 
microscopy. 
 
R-banding with Chromomycin A3. 
To discriminate chromosome and to identify the exact chromosomic 
region R-banding technique has been used. 
 
The solution used for R-banding are: 
- Buffer solution containing phosphate NaH2PO4 and Na2HPO4 
0.14 M; pH 6.8. 
- NaCl – Hepes Buffer 0.15 M (pH 7.0), 0.005 M Hepes. 
 
Slides are treated for 10 minutes with phosphate buffer solution before 
Chromomycin A3 addition and leaved for 2 hours in humid chamber 
at room temperature. 
The slides are briefly rinsed with NaCl – Hepes buffer and treated with 
methyl green solution for 15 minutes with no light exposure at room 
temperature; following two washes in NaCl-Hepes buffer, antifading 
solution is added (antifading:isopropilgallate, 1:300). The slides are 
stored 2-3 days at dark at 4°C before observation. 
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Fluorescent in situ Hybridization (FISH). 
 
Probes selection 
To circumscribe the fragile regions region, after a screening on 
www.genomedataviewer.com we chose a set of probes for each break: 
the proximal one, located between the centromere and the fragile 
region, and distal one between the fragile region and the telomere.  
 
 1p31.3 3q13.3 
Proximal RP11-297N6 RP11-324H4 
Distal RP11- 316C12 RP11-305I9 
Table 3 - Proximal and distal probes used for each putative CFS. 
 
Bacterial cells culture and DNA extraction 
The E. coli cells containing vectors are cultured for 16-20 hours in 50 
mL tubes in 2x YT medium, (3.5% tryptone, 2.0% yeast extract, 0.5% 
NaCl), containing either 20 μg/mL chloramphenicol or 50 μg/ml 
kanamycin for BACs and PACs selection respectively1. 
 
The tubes are centrifuged at 4000 rpm for 7 minutes, the resuspension 
of pellet by GTE addition (50 mM Glucose, 25 mM Tris pH 8, 10 Mm 
EDTA). 
The denaturation solution freshly made (0.2 N NaOH, 1% SDS), 
allows the lysis of bacterial cells before a centrifugation for 10 minutes 
at 14000 rpm; the supernatant containing BAC and genomic DNA is 
poured in new tubes. The addition of ammonium acetate 7.5 M and the 
subsequent centrifugation at 13000 rpm for 20 minutes, helps the 
precipitation of supercoiled genomic DNA and proteins, while the 
BAC, lighter, remains in solution. The supernatant containing BAC is 
then transferred in new tubes and the isopropanol addition promotes 
the BAC precipitation; after another centrifugation (14000 rpm for 20 
minutes) the supernatant is discarded, the pellet is suspended in 70% 
ethanol to remove salts, and another centrifugation at 14000 for 5 
                                                 
1 BACs and PACs have been kindly provided by Professor Mariano Rocchi (University 
of Bari). 
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minutes allows the removal of supernatant. The pellet containing the 
BAC DNA is suspended in TE buffer (10 mM Tris - HCl pH 8.1, 1 
mM EDTA pH 8.0) containing RNase (final concentration 100 μg / 
mL) and later incubated for 30 minutes at 37°C.  
The addition of 1/10 volume of Sodium Acetate and 3 volumes of 
Ethanol helps pelleting the BAC DNA, after 20 minutes of incubation 
at -20°C. A last centrifugation at 14000 rpm for 15 minutes removes 
RNA and salts; the pellet is suspended in an appropriate TE buffer 
volume, checked on 1% agarose gel and stored at 4°C. 
 
Probes labeling through Nick Translation 
Nucleotides are modified with biotin or digoxigenin introduction 
based on the revelation methods; indirect labeling methods and 
biotin/streptavidin or digoxigenin/alfa - digoxigenin systems are used 
in signal revelation. 
 
50 μL reaction solution contains: 
- 1 μg of DNA 
- DNA polymerase I buffer reaction (0.5 M Tris-HCl [pH 7.8], 
50 mM MgCl2, 0.5 mM Bovine Serum Albumin (BSA)); 
- dATP, dCTP, dGTP non- labeled mixture (0.5 M); 
- bio-16-dUTP or dig-16-dUTP labeled dTTP or labeled dTTP 
(0.5 M); 
- β-mercaptoethanol (0.01 M); 
- DNase I and DNA polymerase I (1:500); 
-  Ultrapure distilled H2O in variable amount. 
 
The solution is left at 15°C for 2 hours before checking DNA 
fragments on agarose gel. The reaction is blocked by EDTA 0.5 M 
addition (final concentration 10 μM).  
 
Slides pretreatment 
Slides are incubated in humid chamber at 37°C with RNase (100 μg/ml 
in 20x SSC buffer) for 1 hour to allow RNA degradation. 
Slides are dehydrated with 70%, 90% and 100% ethanol washes for 5 
minutes each and air dried. Afterward the slides are aged for 1 hour at 
65°C and then moved at 80°C for exactly 2 minutes to promote DNA 
denaturation; the process is eased by 70% formamide solution in 20x 
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SSC buffer addition. The reaction is blocked with 70% -20°C cold 
ethanol wash; following dehydration with 90% and 100% ethanol, the 
slides are air dried before hybridization. 
 
Probe pretreatment 
200 ng of DNA are precipitated with a solution containing Cot-1 and 
Herring sperm DNA. 1/10 of sodium acetate 3M is added with 3 
volumes of -20°C 100% ethanol and the probe incubated for 1 hour at 
-80°C or overnight at -20°C. The probe is centrifuged at 13000 rpm 
for 15 minutes, and 70% ethanol in equal quantity to the supernatant 
removed is added. Following 10 minutes centrifugation at 13000 rpm 
the pellet is air dried and suspended in hybridization solution 
containing 50% deionized formamide and dextran sulfate 10% in 20x 
SSC buffer. 
The probe is denaturized at 80°C for 8 minutes, transferred on ice and 
incubated at 37°C for 15 minutes to allows the competitor DNA 
association; the probe rests on ice until hybridization. 
 
In Situ hybridization 
The slides are moved to 37°C and hybridization solution containing 
probe is added; slides are closed with rubber cement and leaved in 
humid chamber at 37°C for 18 hours minimum in order to let the 
hybridization between the target DNA on the slides and the probe. 
 
Post-hybridization washes 
After 18 hours the slides are washed 3 times in 1x SSC buffer at 60°C 
for 5 minutes each, the slides are moved in humid chamber at 37°C 
and treated with 3% BSA blocking solution in 0,1% Tween 20 and 4x 
SSC saline buffer. 
Slides are incubated for 30 minutes at 37°C with 1% BSA, 0,1% 
Tween 20 in 1x SSC buffer along with antibodies specific for probes. 
Based on probes labeling the antibodies are chosen among anti-
digoxigenin-rhodamine (1:300, Roche), FITC-anti-digoxigenin 
(1:20), Cy3-streptoavidin (1:300) or FITC- avidin (1:20). The FITC 
and Cy3 fluorophores anti-digoxigenin and avidin conjugated 
respectively allows the probes signal recognition on samples. 
3 washes in 4x SSC and 0.1% Tween 20 at 42°C are made, the slides 
are closed with 1:300 DAPI: antifading solution (Vectashield). 
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The slides can be observed after 1 hour at 4°C. 
 
Immunofluorescence anti-BrdU. 
For replicative state of nuclei detection, after FISH experiments, the 
slides are treated with immunofluorescence against 
bromodeoxyuridine (BrdU). Thymine analogue BrdU, is incorporated 
only in active replication nuclei in S-phase and can be revealed with 
antibodies anti-BrdU. 
The FISH treated slides are washed once with 4x SSC containing 0.1% 
Tween 20 before adding the primary antibody solution anti-
bromodeoxyuridine (1:1000, Thermo-Fisher) in PBS 1x and 5% FBS 
buffer. After antibody incubation, slides are washed 3 times in 1x PBS, 
secondary antibody solution is added containing FITC anti - mouse 
IgG (1:100, Thermo-Fisher) in PBS 1x buffer and set in humid 
chamber for 1-hour minimum prior washing. The slide are washed 4 
times in 1x PBS and closed with DAPI:antifading solution, 1:300 
(Vectashield). 
The slides set overnight at 4°C prior observation. 
 
Microscope slides Observation. 
Slides observation is done through fluorescence microscope connected 
to a CCD camera. 
The chosen fluorophores, and the respective wavelengths are the 
following: 
 
Fluorophores Excitation λmax Emission λmax 
DAPI 365 nm 397 nm  
FITC 494 nm 523 nm  
Cy3 552 nm 565 nm  
Rhodamine B 553 nm 627 nm  
BrdU 350 nm 461 nm 
The differences in the three excitation and emission of fluorophores 
wavelengths grants the observation of three probes at the same time: 
biotin for the first one, digoxygenin for the second and 
biotin/digoxygenin for the third one, the probes will appear as double 
spot signal on sister chromatids. 
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Photos are taken by RSImage software with three different filters, 
merged together and edited through Adobe Photoshop for probes’ 
visualization and position on sister chromatid and interphasic nuclei. 
 
 
Sequence analysis of Fragile regions. 
 
BACs used in FISH experiment were chosen using Genome Data 
viewer online database (https://www.ncbi.nlm.nih.gov/genome/gdv/). 
AT percentage and repetitive elements composition were performed 
using Repeat Masker program (http://www.repeatmasker.org/), a 
program that screens DNA sequences for interspersed repeats and low 
complexity DNA sequences. 
The replication timing analysis was performed using Replication 
domain database (https://www2.replicationdomain.com/), an online 
database resource for storing, sharing and visualizing DNA replication 
timing and transcription data, as well as other numerical epigenetic 
data types. Data is typically obtained from DNA microarrays or DNA 
sequencing. 
 
 
 
 
Consulted Databases. 
 
http://genome.ucsc.edu/cgi-bin/hgGateway 
http://www.genecards.org/ 
http://genome-euro.ucsc.edu/index.html 
http://www.ncbi.nlm.nih.gov/mapview/ 
http://www.repeatmasker.org/ 
http://replicationdomain.org/ 
https://www.ncbi.nlm.nih.gov/genome/gdv/ 
https://cgap.nci.nih.gov/Chromosomes/Mitelman 
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